PIC50PRED: A PIC50 PREDICTION TOOL FOR 5-ALPHA REDUCTASE ENZYME

Authors

  • Urvashi Balekundri
  • Shivakumar Madagi

Abstract

ABSTRACT
Objectives: Prostate cancer is a major health burden all over the world. 5-alpha reductase (5AR) enzyme is a significant drug target for prostate
cancer. Identification of drug targets and their inhibitors are a challenging task in drug designing. The prediction of potential inhibitors against 5AR
may help in designing effective drugs against prostate cancer.
Methods: The compounds having proven inhibitory action against 5AR in experimental settings were trained and tested to build two-dimensional
quantitative structure-activity relationship (2D QSAR) models based on molecular descriptors. The molecular descriptors were extracted from
E-Dragon 1.0 program. The 2D QSAR prediction models were built using linear regression and least median of squares using Weka 3.7. The optimized
2D QSAR models were implemented in a web-based server by employing XAMPP package and using hyper processed language (PHP) as a scripting
language.
Results: The 2D QSAR models were built using molecular descriptors and achieved a positive correlation of 0.69 (r) and 0.46 (r) between predicted
and actual pIC50 from linear regression and least square of median, respectively.
Conclusion: In silico QSAR modeling along with machine learning techniques seems to be a promising approach for prediction of novel 5AR inhibitors.
To serve the scientific community, a web server pIC50 Pred†has been developed which allows the prediction of pIC50 value of any novel compounds
thought to have 5AR inhibitory activity before jumping into in vitro experimental assays.
Availability: The prediction tool is freely available at http://www.biopred.org.
Keywords: 5-alpha reductase, Two-dimensional quantitative structure-activity relationship, pIC50, Weka, Linear regression, Least median of squares.

Downloads

Download data is not yet available.

References

REFERENCES

National Center for Health Statistics, Division of Health Interview

Statistics. National Health Interview Survey Public Use Data File 2014.

Hyattsville, MD: Centres for Disease Control and Prevention.

Hudak SJ, Hernandez J, Thompson IM. Role of 5 alpha-reductase

inhibitors in the management of prostate cancer. Clin Interv Aging

;1(4):425-31.

Ding K, Lu Y, Nikolovska-Coleska Z, Wang G, Qiu S, Shangary S,

et al. Structure-based design of spiro-oxindoles as potent, specific

small-molecule inhibitors of the MDM2-p53 interaction. J Med Chem

;49(12):3432-5.

Li N, Thompson S, Schultz DC, Zhu W, Jiang H, Luo C, et al. Discovery

of selective inhibitors against EBNA1 via high throughput in silico

virtual screening. PLoS One 2010;5(4):e10126.

Núñez MB, Maguna FP, Okulik NB, Castro EA. QSAR modeling of the

MAO inhibitory activity of xanthones derivatives. Bioorg Med Chem

Lett 2004;14(22):5611-7.

Mandal AS, Roy K. Predictive QSAR modelling of HIV reverse

transcriptase inhibitor TIBO derivatives. Eur J Med Chem

;44(4):1509-24.

Pasha FA, Muddassar M, Srivastava AK, Cho SJ. In silico QSAR

studies of anilinoquinolines as EGFR inhibitors. J Mol Model

;16(2):263-77.

Kahraman P, Turkay M. QSAR analysis of 1,4-Dihydropyridine calcium

channel antagonists. In: Plesu V, Agachi PS, editors. 17

European

Symposium on Computer Aided Process Engineering - ESCAPE17.

Amsterdam: Elsevier; 2007.

Zhu J, Lu W, Liu L, Gu T, Niu B. Classification of Src kinase

inhibitors based on support vector machine. QSAR Comb Sci

th

Asian J Pharm Clin Res, Vol 9, Issue 2, 2016, 154-158

Balekundri and Madagi

;28(6-7):719-27.

Garg A, Tewari R, Raghava GP. KiDoQ: Using docking based energy

scores to develop ligand based model for predicting antibacterials.

BMC Bioinformatics 2010;11:125.

Kovalishyn V, Aires-de-Sousa J, Ventura C, Elvas Leitao R, Martins F.

QSAR modeling of antitubercular activity of diverse organic

compounds. Chemometr Intell Lab Syst 2011;107(1):69-74.

Singla D, Anurag M, Dash D, Raghava GP. A web server for predicting

inhibitors against bacterial target GlmU protein. BMC Pharmacol

;11:5.

Maganti L; OSDD Consortium, Ghoshal N. 3D-QSAR studies and

shape based virtual screening for identification of novel hits to

inhibit MbtA in Mycobacterium tuberculosis. J Biomol Struct Dyn

;33(2):344-64.

Chandrabose S, Kumar TS, Konda RK, Kumar S. Tool development for

prediction of pIC50 values from IC50 values-A pIC50 value calculator.

Curr Trends Biotechnol Pharm 2011;5(2):1104-9.

Mishra NK, Agarwal S, Raghava GP. Prediction of cytochrome P450

isoform responsible for metabolizing a drug molecule. BMC Pharmacol

;10:8.

Richard AH, Shutsung L. Methods and Compositions for Regulation of

-alpha Reductase Activity. 1999;WO 1999022728 A1.

Bolton E, Wang Y, Thiessen PA, Bryant SH. PubChem: Integrated

platform of small molecules and biological activities. Ann Rep Comput

Chem 2008;4:217-41.

Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P,

et al. Virtual computational chemistry laboratory – Design and

description. J Comput Aided Mol Des 2005;19(6):453-63.

Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH.

The WEKA data mining software: An update. SIGKDD Explor

;11(1):10-8.

Selvakuberan K, Indradevi M, Rajaram R. Combined feature selection

and classification - A novel approach for the categorization of web

pages. J Inf Comput Sci 2008;3(2):83-9.

Published

01-03-2016

How to Cite

Balekundri, U. ., and S. Madagi. “PIC50PRED: A PIC50 PREDICTION TOOL FOR 5-ALPHA REDUCTASE ENZYME”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 2, Mar. 2016, pp. 154-8, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/10186.

Issue

Section

Original Article(s)